Your browser doesn't support javascript.
loading
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III).
Atkinson, Victoria G; Quaglino, Pietro; Aglietta, Massimo; Del Vecchio, Michele; Depenni, Roberta; Consoli, Francesca; Bafaloukos, Dimitrios; Ferrucci, Pier Francesco; Tulyte, Skaiste; Krajsová, Ivana; Ascierto, Paolo A; Gueli, Rossana; Arance, Ana; Gogas, Helen; Banerjee, Hiya; Saliba, Teddy; de Jong, Egbert; Neyns, Bart.
Affiliation
  • Atkinson VG; Division of Cancer Services, Princess Alexandra Hospital, University of Queensland, Brisbane, QLD 4102, Australia.
  • Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, 10124 Turin, Italy.
  • Aglietta M; Department of Oncology, University of Torino, 10124 Turin, Italy.
  • Del Vecchio M; Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo (Torino), Italy.
  • Depenni R; Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
  • Consoli F; Department of Oncology and Hematology, University of Modena and Reggio Emilia, 41121 Modena, Italy.
  • Bafaloukos D; Medical Oncology, ASST Spedali Civili, 25123 Brescia, Italy.
  • Ferrucci PF; Medical Oncology, Metropolitan Hospital, 18547 Athens, Greece.
  • Tulyte S; Tumor Biotherapy Unit, Department of Experimental Oncology, IEO-Istituto Europeo di Oncologia-IRCCS, 20141 Milan, Italy.
  • Krajsová I; Hematology, Oncology and Transfusion Medicine Center, Vilnius University, 08410 Vilnius, Lithuania.
  • Ascierto PA; Department of Dermatovenerology, University Hospital Prague, Charles University, 12808 Prague, Czech Republic.
  • Gueli R; Melanoma Unit, Cancer Immunotherapy and Innovative Therapies, Istituto Nazionale Tumori-IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.
  • Arance A; Oncology Unit, ASST Sette Laghi, 21100 Varese, Italy.
  • Gogas H; Department of Medical Oncology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.
  • Banerjee H; Department of Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens School of Medicine, 11527 Athens, Greece.
  • Saliba T; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • de Jong E; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA.
  • Neyns B; Novartis AG, 4057 Basel, Switzerland.
Cancers (Basel) ; 13(10)2021 May 18.
Article in En | MEDLINE | ID: mdl-34070224
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: Australia